Aeterna Zentaris
AEZS
#10128
Rank
NZ$29.48 M
Marketcap
NZ$9.63
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): NZ-$3.38

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is NZ-$3.45. In 2022 the company made an earnings per share (EPS) of NZ-$7.88 a decrease over its 2021 EPS that were of NZ-$3.06.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$3.38
2022NZ-$7.88157.14%
2021NZ-$3.06-41.48%
2020NZ-$5.24-64.46%
2019NZ-$14.73-240%
2018NZ$10.52-122.32%
2017NZ-$47.15-53.53%
2016NZ-$101.45-86.71%
2015NZ-$763.65-35.21%
2014NZ-$1,179-216.67%
2013NZ$1,010-123.3%
2012NZ-$4,336-40.8%
2011NZ-$7,325-6.45%
2010NZ-$7,830-27.91%
2009NZ-$10,861-61.61%
2008NZ-$28,28983.61%
2007NZ-$15,408-195.31%
2006NZ$16,165178.26%
2005NZ$5,809-330%
2004NZ-$2,526-80.05%
2003NZ-$12,66117.78%
2002NZ-$10,750515.93%
2001NZ-$1,745-68.6%
2000NZ-$5,559119.62%
1999NZ-$2,531-3.63%
1998NZ-$2,626

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.39-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$3.48-200.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$5.00-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.61-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$8.23-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA